Brief: Healius To Sell Agilex Biolabs To Novotech
25/09/2026 02:28
BRIEF-Healius To Sell Agilex Biolabs To Novotech Sept 25 (Reuters) - Healius Limited HLS.AX:
AGREEMENT TO SELL AGILEX BIOLABS TO NOVOTECH
AGREES TO SELL AGILEX BIOLABS FOR ENTERPRISE VALUE OF A$160 MILLION
COMPLETION OF AGILEX BIOLABS SALE ANTICIPATED DURING H2 FY2027
DEAL EXPECTED TO RESULT IN CASH PROCEEDS OF ABOUT A$155 MILLION
Further company coverage: HLS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Healius
See all newsAustralia's Healius rises on sale of unit Agilex; Jefferies lifts PT
Brief: Healius To Sell Agilex Biolabs To Novotech
Australia's Healius rises on sale of unit Agilex Biolabs to Novotech Health
Brief: Healius Requests Trading Halt
Brief: Healius Expects To Achieve T27 Target Of Mid-To-High Single-Digit EBIT Margins By Dec 2028